Art Orentas - Company finances
- The company has not submitted financial data for these years: 2022, 2023.
|
EUR
|
2020
From: 2020-09-08
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | - | 12,965 | 20,920 |
| Profit before tax | 0 | 0 | 3,754 | -3,478 |
| Net profit | 0 | 0 | 3,566 | -3,478 |
| Equity | 0 | 0 | 3,566 | 88 |
| Liabilities | - | - | 483 | 532 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 0 | 0 | 4,049 | 620 |
| Total assets | 0 | 0 | 4,049 | 620 |
|
Taxes paid
|
||||
| STI taxes | - | - | 152 | 188 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | - | +61.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | 88.1% | -561.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 100.0% | -3952.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | 27.5% | -16.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 29.0% | -16.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.1 | 6.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Art Orentas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 160.88 |
| 2026-08-26 | 2026-08-31 | 80.40 |
| 2026-08-23 | 2026-08-23 | 80.40 |
| 2026-08-19 | 2026-08-19 | 80.40 |
| 2026-08-16 | 2026-08-17 | 80.40 |
| 2026-08-01 | 2026-08-14 | 80.40 |
| 2026-07-01 | 2026-07-31 | 160.92 |
| 2026-06-02 | 2026-06-30 | 80.44 |
| 2026-05-03 | 2026-05-31 | 160.96 |
| 2026-04-01 | 2026-04-30 | 80.48 |
| 2025-11-01 | 2025-11-30 | 72.45 |
| 2025-10-01 | 2025-10-31 | 80.20 |
| 2025-09-27 | 2025-09-30 | 7.75 |
| 2025-09-02 | 2025-09-26 | 80.20 |
| 2025-08-01 | 2025-09-01 | 7.75 |
| 2025-07-01 | 2025-07-31 | 80.30 |
| 2025-06-03 | 2025-06-30 | 7.85 |
| 2025-04-01 | 2025-04-30 | 7.95 |
| 2025-03-01 | 2025-03-31 | 15.90 |
| 2025-02-01 | 2025-02-28 | 7.95 |
Art Orentas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-19 | 2025-06-30 | 188.1 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Art Orentas, MB (code 305421180) is a small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, the company generated revenue of €20.9K, up 61.4% year on year from €13.0K in 2024. However, the stronger turnover did not translate into profitability: net profit changed from €3.6K in 2024 to a net loss of €3.5K in 2025, and the profit margin fell to -16.6%. The two-year trend therefore shows revenue growth alongside a sharp deterioration in earnings. The balance sheet also weakened in 2025, with total assets of €620, equity of €88 and liabilities of €532, compared with assets of €4.0K, equity of €3.6K and liabilities of €483 in 2024. Return on equity and return on assets were strongly negative, but these ratios are heavily affected by the very small equity and asset base. Asset turnover was very high relative to that base.